Market Closed

GPCR
Structure Therapeutics
$ 20.00
0.81%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Structure Therapeutics News

Latest Structure Therapeutics Stock News & GPCR Headlines

Structure Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights
5 days ago | globenewswire.com
Novo Up 4% in a Month: How Should Investors Approach the Stock Now?
6 days ago | zacks.com
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Stock Has Consensus Price Target of $110.91 According to Brokerages
25 days ago | defenseworld.net
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2026
a month ago | globenewswire.com
Novo Down 11% in a Month: How Should Investors Approach the Stock Now?
a month ago | zacks.com
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Stock Rated “Moderate Buy” by Sell-Side Brokerages
2 months ago | defenseworld.net
Structure Therapeutics Inc. (GPCR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
2 months ago | seekingalpha.com
Structure Therapeutics: The Amylin Data Changes The Math
2 months ago | seekingalpha.com
Structure Therapeutics Inc. (GPCR) Discusses Positive Clinical Data Updates for Oral Small Molecule Amylin and GLP-1 Programs in Chronic Weight Management Transcript
2 months ago | seekingalpha.com
Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
2 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

GPCR
Structure Therapeutics
$ 20.00
0.81%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago